The necessity of human trials of putative therapies for Alzheimer's disease

Research output: Contribution to journalArticle


The absence of a suitable animal model for Alzheimer's disease leaves therapeutic trials in human subjects as a necessity. Reasonable criteria can be formulated for deciding which therapies should be tested. Scientific rationale and likelihood of success should be major considerations. Novel approaches of delivering drugs to the central nervous system should not be discouraged so long as complication rates can be shown to be low.

Original languageEnglish (US)
Pages (from-to)633-634
Number of pages2
JournalNeurobiology of Aging
Issue number5
StatePublished - 1989
Externally publishedYes


ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry
  • Developmental Neuroscience
  • Neurology
  • Psychology(all)

Cite this